A pilot randomized controlled trial of the effects of dietary nitrate supplementation on dynamic cerebral autoregulation in older adults with metabolic syndrome
Abstract
Metabolic syndrome (MetS) is associated with reduced nitric oxide (NO) bioavailability and impaired cerebrovascular function, potentially increasing cognitive decline risk. Dynamic cerebral autoregulation (dCA) maintains cerebral blood flow and may involve NO-related vascular mechanisms. Whether dietary nitrate supplementation influences dCA in MetS remains unclear. This pilot trial evaluated feasibility and explored effects of nitrate supplementation on dCA. Twenty-two older adults with MetS (55-75 years) were randomized in a double-blind, placebo-controlled design to receive nitrate-rich beetroot juice (BRJ; 6.4 mmol NO3 -·day-1) or nitrate-depleted placebo for 4 week. dCA was assessed using transfer function analysis (TFA) of beat-to-beat blood pressure and functional near-infrared spectroscopy-derived cerebral oxygenation. Primary analyses examined frontal dCA holistically, with exploratory regional and cognitive outcomes. dCA was indexed by TFA phase and gain. The intervention was well tolerated, adherence was high, and BRJ increased plasma nitrate concentrations versus placebo (p < 0.001). No significant effects were observed for frontal dCA or cognition. Exploratory analyses indicated region-specific differences in dCA in select frontal areas, characterized by improvements in TFA phase and gain. This pilot trial demonstrates the feasibility of dietary nitrate supplementation in MetS. While no effects were observed in primary outcomes, exploratory analyses suggest…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.